For research use only. Not for therapeutic Use.
BPKDi（Cat No.:I012766）is a selective inhibitor of Bruton’s tyrosine kinase (BTK), an enzyme crucial for B-cell receptor signaling and immune cell activation. By targeting BTK, BPKDi can modulate immune responses, making it a promising candidate for treating autoimmune diseases, such as rheumatoid arthritis and lupus, where abnormal B-cell activation plays a central role. Additionally, BPKDi shows potential in targeting certain cancers, especially B-cell malignancies like chronic lymphocytic leukemia. Its ability to inhibit BTK signaling may help reduce inflammation, prevent disease progression, and enhance therapeutic outcomes in affected patients.
| CAS Number | 1201673-28-0 |
| Synonyms | 2-[2-(cyclohexylamino)pyridin-4-yl]-6-piperazin-1-ylpyridine-4-carboxamide |
| Molecular Formula | C21H28N6O |
| Purity | ≥95% |
| IUPAC Name | 2-[2-(cyclohexylamino)pyridin-4-yl]-6-piperazin-1-ylpyridine-4-carboxamide |
| InChI | InChI=1S/C21H28N6O/c22-21(28)16-12-18(26-20(14-16)27-10-8-23-9-11-27)15-6-7-24-19(13-15)25-17-4-2-1-3-5-17/h6-7,12-14,17,23H,1-5,8-11H2,(H2,22,28)(H,24,25) |
| InChIKey | XNWDRALEEPGBHB-UHFFFAOYSA-N |
| SMILES | C1CCC(CC1)NC2=NC=CC(=C2)C3=NC(=CC(=C3)C(=O)N)N4CCNCC4 |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
